@astrazeneca.com's drug scores two late-stage trial wins as full data boosts blockbuster hopes

@astrazeneca.com's drug scores two late-stage trial wins as full data boosts blockbuster hopes
A study found semaglutide was associated with nearly 40 percent fewer asthma attacks and 20 percent fewer COPD flare-ups, while three other GLP-1 drugs showed no such association.
youtu.be/X-mMZk2gSqI
#Semaglutide #Ozempic #Wegovy #GLP1 #GLP1Drugs #Asthma #COPD #LungHealth #RespiratoryHealth
Two international #ClinicalTrials found that the investigational #BiologicTherapy #tozorakimab significantly reduced #COPD flare-ups in patients receiving standard treatment.
#LungDisease
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more news.. statnews.com/pharmalot/20... #pharma #FDA #COPD #tariffs #HIV #weight #obesity #Lilly #AstraZeneca #SouthAfrica
ICYMI: AstraZeneca's new COPD drug works where others can't #AstraZeneca #COPD
The #FDA has started a #priorityreview of #AstraZeneca's IL-33-targeting antibody #tozorakimab for chronic obstructive pulmonary disease (#COPD), setting up a decision on the would-be blockbuster in the first quarter of 2027.
😆 Deliberate #laughter therapy offers an effective low-cost complementary treatment to help patients with #COPD reduce #breathing difficulties at home without specialist support, new research presented at the @europeanrespsoc.bsky.social's #ERSCongress finds.
Presented by our Editorial Review Board member Guilherme Rodrigues at #ERSCongress2026, this poster explored inhaled therapy changes following COPD exacerbations in primary care.
Check it out👇
Altesa BioSciences Reveals Positive Vapendavir Data for COPD Treatment at ERS 2026 #Spain #Barcelona #COPD #Altesa_BioSciences #Vapendavir
#Semaglutide linked to 20% fewer #COPD flare-ups and nearly 40% fewer #asthma attacks. The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at #ERS Congress in Barcelona, Spain. medicalxpress.com/ne...
AstraZeneca's new COPD drug works where others can't #AstraZeneca #COPD
Patient Education - Living with COPD
Assessing your COPD, Treating your COPD, Understanding your COPD, Using your Inhaler, Medications & Practical Tips. #COPD Learn more: www.copdcanada.info/patient-education
Wenn Sie #Krebs oder #Asthma oder #COPD haben, oder überhaupt #chronischkrank sind, dann wäre das schon gut, wenn Ärzte, die so einen Knoten in ihrer Lunge entdecken, Ihnen auch mitteilen, dass Sie das da haben, insbesondere wenn es größer acht 8 mm ist.
Not all airway #CiliatedCells are alike.
This study maps their diversity, revealing region-specific antioxidant defenses and disease-linked signatures that could guide new therapies for #asthma and #COPD. #RespiratoryDiseases
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...
Ameera Patel, chief executive of TidalSense, writes that while cancer research gets £419 million a year, all of respiratory disease gets only £16 million.
healthcaretoday.com/article/comm...
#COPD #RespiratoryHealth #HealthResearch #HealthInequalities #NHS
A great poster from the TAR community at #ERSCongress2026, exploring eligibility for type 2 biologic therapy in COPD. Congratulations to Prof. Antonio Spanevello, Marco Vanetti, and colleagues. #COPD #RespiratoryResearch
🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TVL85W #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII